Gastrointestinal Microbiome Study of Appendiceal Cancer

Status Recruiting

Clinical Trial Summary

This study analyzes the gastrointestinal microbiome of appendiceal cancer patients with peritoneal spread scheduled to undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Participants will provide fecal samples pre- and post-operatively.

Clinical Trial Description

Analysis of the human microbiome is an attempt to define how changes in the human microbiome are associated with health or disease. Eligible participants scheduled to undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal cancer will provide fecal samples pre- and post-operatively. Investigators will analyze potential changes in the gastrointestinal microbiome and make comparisons to an age-matched healthy sample. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02599116
Study type	Interventional
Source	Mercy Medical Center
Contact	Mary Caitlin King
Phone	410-332-9294
Email	mking5@mdmercy.com
Status	Recruiting
Phase	N/A
Start date	December 2015
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04024917` - Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis	N/A
Completed	`NCT02374411` - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients	N/A
Recruiting	`NCT02073500` - Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Active, not recruiting	`NCT01427101` - Results of CRS and Debulking in PMP Patients	N/A
Active, not recruiting	`NCT04982146` - Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei	Phase 1
Completed	`NCT04088786` - Phase I Trial HIPEC With Nal-irinotecan	Phase 1
Not yet recruiting	`NCT06084780` - Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)	Phase 2
Active, not recruiting	`NCT02834169` - French National Registry of Rare Peritoneal Surface Malignancies	N/A
Completed	`NCT01764789` - Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer	N/A
Completed	`NCT02040142` - Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C	Phase 2
Withdrawn	`NCT04125225` - What Are the Experiences of Patients With Pseudomyxoma Peritonei?
Not yet recruiting	`NCT03976973` - BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei	Phase 2
Recruiting	`NCT01617382` - Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Completed	`NCT01652794` - Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer	Phase 1
Completed	`NCT01126346` - Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	N/A
Completed	`NCT05513183` - Severe Neutropenia After HIPEC Using Mitomycin-C
Active, not recruiting	`NCT02834013` - Nivolumab and Ipilimumab in Treating Patients With Rare Tumors	Phase 2
Recruiting	`NCT03210298` - International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
Active, not recruiting	`NCT02387203` - Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin	Phase 2
Terminated	`NCT04665921` - A Study of SGN-STNV in Advanced Solid Tumors	Phase 1